ReviewPharmaceutics2026

Intranasal vs. Device-Assisted Drug Delivery: Advantages and Limitations for the Delivery of Biopharmaceuticals to the CNS.

Lisa Benedetta De Martini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.